Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T van Dissel

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
The Netherlands Journal of Medicine|January 11, 2000
Infectious diseases into the next millenniumJ T van Dissel
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 16, 2002
Procalcitonin and other markers of infection. What should be their role in clinical practice?J T van Dissel
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2017
[Enterovirus type D68 and acute flaccid paralysis: a new duo?]J T van Dissel, A Meijer
Nederlands Tijdschrift Voor Geneeskunde|April 3, 2002
[Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]E F Schippers, J T van Dissel
Agents and Actions|January 1, 1989
Interferon-gamma does not enhance the bactericidal activity of murine macrophagesR van Furth, J T van Dissel
Critical Care Medicine|November 8, 2003
Selective gut decontaminationE F Schippers, J T van Dissel
Lancet (London, England)|September 24, 1994
Serum nitric oxide and morbidity in postoperative patientsJ T van Dissel, P H Groeneveld
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]F P Kroon, J T van Dissel
FEMS Microbiology Immunology|April 1, 1989
Is the conventional doctrine about macrophage activation still true?R van Furth, J T van Dissel
Nederlands Tijdschrift Voor Geneeskunde|October 6, 2000
[From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis]J T van Dissel, T H Ottenhoff
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
The Netherlands Journal of Medicine|January 11, 2000
Infectious diseases into the next millenniumJ T van Dissel
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 16, 2002
Procalcitonin and other markers of infection. What should be their role in clinical practice?J T van Dissel
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2017
[Enterovirus type D68 and acute flaccid paralysis: a new duo?]J T van Dissel, A Meijer
Nederlands Tijdschrift Voor Geneeskunde|April 3, 2002
[Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review]E F Schippers, J T van Dissel
Agents and Actions|January 1, 1989
Interferon-gamma does not enhance the bactericidal activity of murine macrophagesR van Furth, J T van Dissel
Critical Care Medicine|November 8, 2003
Selective gut decontaminationE F Schippers, J T van Dissel
Lancet (London, England)|September 24, 1994
Serum nitric oxide and morbidity in postoperative patientsJ T van Dissel, P H Groeneveld
Nederlands Tijdschrift Voor Geneeskunde|June 26, 2003
[Splenectomy and pneumococcal vaccination]F P Kroon, J T van Dissel
FEMS Microbiology Immunology|April 1, 1989
Is the conventional doctrine about macrophage activation still true?R van Furth, J T van Dissel
Nederlands Tijdschrift Voor Geneeskunde|October 6, 2000
[From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis]J T van Dissel, T H Ottenhoff
Pageof 15